Journal of International Medical Research

Criteria for Publication

Our goal is to publish research done well. This means we look for research that adds to the academic record, either as novel or corroborative evidence, and adheres to ethical standards, uses robust methodologies that are transparent and reproducible, and uses appropriate statistical analyses to ensure clear, credible, and trustworthy results. The Journal of International Medical Research evaluates manuscripts based on how the research was conducted and reported.

• All manuscripts:

• must comply with the Helsinki Declaration of 1975 and EQUATOR Network reporting guidelines (e.g. CONSORT for randomized, controlled trials, PRISMA for systematic reviews/meta-analyses, STROBE for most observational studies, ARRIVE for animal studies and CARE for case reports).

• are subject to single-blind peer review (comments from at least two external peer reviewers).

• receive high-quality scientific and language editing before publication.

• must follow our publishing policies.

• The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.

Scope

The Editors are looking for medical research that adds to the existing literature either as novel or corroborative evidence. We will consider replication studies and negative/null results studies.

We welcome manuscripts across all the main fields, branches, specialties (and subspecialties) and therapeutic areas of medicine. This includes: allergy and immunology, anaesthesia and analgesia, bioinformatics, cardiology, cardiovascular system, clinical epidemiology, clinical pharmacology, critical care, dentistry, dermatology, diabetes and endocrinology, emergency medicine, gastroenterology, geriatrics, haematology, hepatology, immunology, infectious disease, men’s health, musculoskeletal disease, nephrology, neurology, obstetrics and gynaecology, oncology (all solid tumours), ophthalmology, oral and dental health, orthopaedics, otorhinolaryngology, paediatrics and neonatology, pharmacology, psychiatry, regenerative medicine, respiratory disease, rheumatology, sexual health, sports medicine, surgery (all areas), therapeutics, urology, women’s health.

We publish original clinical research (randomised controlled trials, observational studies) and preclinical research (in vitro studies, animal studies, in silico studies), systematic reviews and meta-analyses, narrative reviews, and case reports/series.

We do not publish the following research:

• Public health studies, social/nursing care studies, epidemiology studies, health economics and outcomes research

• Alternative and complementary medicine

• Bioinformatics without clinical, in vitro, or in vivo validation

• in vitro cell lines studies without in vivo/clinical validation; in silico studies without supporting evidence of their downstream effects in vivo or in vitro

• Simple database studies, simple bibliographic studies, common cases

• Studies with limited international appeal that are more suited for a local or niche journal

• Life science and engineering studies: these may be suitable for our sister publication, Science Progress.

You can submit a manuscript at any time. Please also consider our lists of Special Topics and Special Collections.